AC Immune (ACIU) Total Liabilities (2015 - 2026)
AC Immune (ACIU) posted quarterly Total Liabilities of $135.2 billion for Q1 2026, up 104447.23% year-over-year from N/an in Q1 2025, and up 98717.21% quarter-over-quarter from $136.8 million in Q4 2025.
AC Immune (ACIU) Total Liabilities (2015 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Total Liabilities for 12 consecutive years, with $135.2 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 104447.23% year-over-year to $135.2 billion; the TTM figure through Mar 2026 stood at $135.2 billion (up 104447.23% YoY), while the FY2025 annual figure was $131.9 million, down 2.6% from the prior year.
- Total Liabilities advanced to $135.2 billion in Q1 2026 per ACIU's latest filing, from $136.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $135.2 billion in Q1 2026 and bottomed at $14509.1 in Q2 2022.
- Historically, Total Liabilities has averaged $8.0 billion across 5 years, with a median of $25.9 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities plunged 44.95% — and 2023, when it surged 129444.62%.
- AC Immune's Total Liabilities stood at $17.6 million in 2022, then surged by 42.08% to $25.0 million in 2023, then soared by 441.85% to $135.4 million in 2024, then grew by 1.04% to $136.8 million in 2025, then jumped by 98717.21% to $135.2 billion in 2026.
- Business Quant data shows ACIU's Total Liabilities at $135.2 billion in Q1 2026, $136.8 million in Q4 2025, and $136.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | 145.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 145.80 Mn |
| Mar 31, 2026 | 135.22 Bn |
| Dec 31, 2025 | 136.84 Mn |
| Sep 30, 2025 | 136.47 Mn |
| Jun 30, 2025 | 139.49 Mn |
| Mar 31, 2025 | 129.34 Mn |
| Dec 31, 2024 | 135.43 Mn |
| Sep 30, 2024 | 131.68 Mn |
| Jun 30, 2024 | 126.18 Mn |
| Mar 31, 2024 | 25.89 Mn |
| Dec 31, 2023 | 24.99 Mn |
| Sep 30, 2023 | 19.61 Mn |
| Jun 30, 2023 | 18.80 Mn |
| Mar 31, 2023 | 17.53 Mn |
| Dec 31, 2022 | 17.59 Mn |
| Sep 30, 2022 | 16.05 Mn |
| Jun 30, 2022 | 14,509.11 |
| Mar 31, 2022 | 23,159.11 |
| Dec 31, 2021 | 31.95 Mn |
| Sep 30, 2021 | 26,329.70 |